Symlin News

Latest Symlin News from Pharmaceutical Industry Today

Drugs > Symlin

Amylin Pharmaceuticals' CEO Discusses Q1 2012 Results - Earnings Call Transcript
27 Apr 00:53 GMT

… physicians an important new treatment option providing improved … have 10-plus years of pharmaceutical or biotech sales experience. … . Moving on to SYMLIN. SYMLIN prescriptions declined by 10 … endo-mimetics, doctors who prescribe a lot of diabetes drugs …
Carl Icahn Sues Amylin Pharmaceuticals, Pushes For Sale
10 Apr 14:30 GMT

… Carl Icahn sued Amylin Pharmaceuticals Inc to block enforcement … makes diabetes medications that include Bydureon, Byetta and Symlin. Like … two board seats at biotechnology company Biogen Idec Inc. … The type 2 diabetes treatment became available by …
Amylin Pharmaceuticals: Enter Carl Icahn And The Proxy Battle
4 Apr 20:18 GMT

… turning his sights to Amylin Pharmaceuticals (AMLN). And as history … to properly commericizlize the drug. Our first article on … more debt than 90% of biotechnology companies, and it faces … commercial products, Bydureon, Byetta and Symlin, which may not be …
Icahn Issues Open Letter to the Board of Directors of Amylin Pharmaceuticals
4 Apr 12:22 GMT

… April 4, 2012 Amylin Pharmaceuticals, Inc. 9360 Towne Centre … products, Bydureon, Byetta and Symlin, which may not be … February 16, 2012 report stating that at least 9 … biotech companies are great at developing innovative products to meet unmet medical …
Amylin Pharmaceuticals: Unless A Bidding War Is Ignited, Tender
29 Mar 09:48 GMT

… from its diabetes drug Bydureon for which it received FDA approval as … tried to acquire new promising pharmaceutical and biotechnological companies as its patents … as its current medicines "BYETTA" and "SYMLIN" are …
Amylin Pharmaceuticals Pulling Ahead Of Roche In Anti-Obesity Drugs?
18 Mar 16:37 GMT

… in diabetes. Amylin Pharmaceutical's Answer Amylin Pharmaceuticals (AMLN) is … with taking a pill or several pills a day for … those who take the medication. The analogue, called Symlin, is effective … ;s Choice for Obesity Treatment Roche (RHHBY.PK) can …
Amylin Pharmaceuticals Announces Pricing of Public Offering of Common Stock
8 Mar 14:13 GMT

… jurisdiction. About Amylin Pharmaceuticals Amylin Pharmaceuticals is a biopharmaceutical … and commercialization of innovative medicines. Amylin is committed … risks that our clinical trials will not be … the potential for BYETTA, SYMLIN or BYDUREON. These …
Amylin Pharmaceuticals Announces Public Offering of Common Stock
7 Mar 21:53 GMT

… jurisdiction. About Amylin Pharmaceuticals Amylin Pharmaceuticals is a biopharmaceutical … and commercialization of innovative medicines. Amylin is committed … risks that our clinical trials will not be … the potential for BYETTA, SYMLIN or BYDUREON. These …
Amylin: Is This Biotech A Buy Right Now?
6 Mar 17:26 GMT

… a look at Amylin Pharmaceuticals Inc. (NASDAQ: AMLN), a … medications, to see if it is worth buying into this biotech … treatment, but some will prefer to stay with the medication … other medications, such as Symlin, are doing well enough too. Symlin …
Weight affected by some medications
26 Feb 21:13 GMT

… types of medicine or dosages taken, Roux added. Common medications and their weight side effects include drugs for: Diabetes … , or exenatide; Januvia, or sitagliptin; Symlin, or pramlintide; Metformin; and Precose …
Amylin Pharmaceuticals Posts 4Q and Full Year 2011 Financial Results [Professional Services Close - Up]
11 Feb 10:11 GMT

… U.S. Food and Drug Administration (FDA) approval for BYDUREON ( … European Union for the treatment of type 2 diabetes. … $28.3 million for SYMLIN (pramlintide acetate) injection. This … period in 2010. Amylin Pharmaceuticals is a biopharmaceutical company …
Amylin Pharmaceuticals' CEO Discusses Q4 2011 Results - Earnings Call Transcript
7 Feb 02:37 GMT

… , and welcome to Amylin Pharmaceuticals' quarterly update conference … the SYMLIN vial and converted patients to the SYMLIN pen. … . Having described the accounting treatment of the major complements … to confuse all the biotech analysts with accounting jargon. …
Amylin Pharmaceuticals Reports Fourth Quarter and Full Year 2011 Financial Results
6 Feb 21:48 GMT

… U.S. Food and Drug Administration (FDA) approval for BYDUREON … European Union for the treatment of type 2 diabetes. … GAAP. About Amylin Pharmaceuticals Amylin Pharmaceuticals is a biopharmaceutical company … including risks that BYETTA, SYMLIN or BYDUREON, and …
Amylin Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference
3 Jan 13:05 GMT

… audio software. About Amylin Pharmaceuticals Amylin Pharmaceuticals is a biopharmaceutical company dedicated … approval for two first-in-class medicines for diabetes, SYMLIN(Â®) (pramlintide acetate) injection …
Amylin Pharmaceuticals Announces Date and Time Change to Previously Announced Presentation at the Credit Suisse 2011 ...
9 Nov 13:25 GMT

… audio software. About Amylin Pharmaceuticals Amylin Pharmaceuticals is a biopharmaceutical company dedicated … approval for two first-in-class medicines for diabetes, SYMLIN® (pramlintide acetate) injection and …
Amylin Pharmaceuticals' CEO Discusses Q3 2011 Results - Earnings Call Transcript
20 Oct 02:34 GMT

… and welcome to Amylin Pharmaceuticals Quarterly Update Conference Call. … regard to SYMLIN, as Mark mentioned earlier, SYMLIN revenues … postprandials as a mealtime treatment option instead of … I watched several different doctors go through the experience …
Amylin Pharmaceuticals Reports Third Quarter Financial Results
19 Oct 20:16 GMT

… Amylin Pharmaceuticals. "Additionally, we look forward to the FDA … the DURATION-3 and -4 trials. The studies demonstrated … received commonly prescribed diabetes treatments Obesity Program -- Announced … including risks that BYETTA, SYMLIN or BYDUREON, and …
Amylin Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
7 Sep 20:17 GMT

… audio software. About Amylin Pharmaceuticals Amylin Pharmaceuticals is a biopharmaceutical company dedicated … approval for two first-in-class medicines for diabetes, SYMLIN® (pramlintide acetate) injection and …
Collaborations Between Biotechnology Companies And Government/Nonprofit Institutions: March 1 - August 19, 2011
22 Aug 18:29 GMT

… Symlin is approved as an adjunct treatment … trials (5/20) Â JUNE Â Affiris AG (Vienna, Austria) Medical … treatment of cancer Financial terms were not disclosed (7/22) BioSante Pharmaceuticals … agreements between biotech companies and clinical trial centers. …
Amylin Pharmaceuticals tumbles on Bydureon’s Approval Agenda Update
11 Aug 16:35 GMT

… Shares of Amylin Pharmaceuticals Inc. (Nasdaq: AMLN … drug and changes in heart rhythms. Moreover, the company’s trials … medical treatment. Amylin developed and gained approval in 2005 for two first-in-class medicines … energy stocks, biotech stocks, oil stocks …
Takeda and Amylin pull the plug on obesity combo drug
5 Aug 11:39 GMT

… the latter's diabetes drug Symlin and metreleptin. The companies say … reassessment" of the drug, which comprises Symlin (pramlintide), an analogue of …

1 2 3 4 5 6 7 8 Next

PHARMACEUTICAL INDUSTRY TODAY			BACK TO TOP

Account Info:

My Account
Subscriber Billing Info
Member Center
- Change your billing and/or user information
- Extend your subscription period
- Re-activate an expired account
- Manage your Email Alerts
- Add additional users to your account
- Manage your additional user account(s)
- Retrieve a lost password
- Get an invoice for your subscription
- Cancel your account by sending us an email through the feedback form

Create an Account:

Help & Information Center:

Submit

About

Navigate:

Tools and Formats:

EIN News Home
About EIN News

Founded in 1995, EIN News is an international leader in real-time news tracking and digital information services. Our systems continuously scan the web, indexing news from thousands of worldwide sources. The data is then filtered and organized into news streams. The process is supervised by a team of professional news editors.

We are news professionals and technologists dedicated to producing the fastest and most comprehensive news streams on the planet. We are committed to providing our members with the highest quality software tools and resources available.

EIN News is a division of Internet Product Development Group Inc.
To reach us send an email or call +1 202 657 5158.
EIN Presswire
EIN Marketplace
EIN Events and Conferences
Newsfeed Maker
Inbox Robot
IPD Group
EIN Twitter
EIN Facebook

+ Pharmaceutical Industry Today = Unlimited access to real-time news

Create your EIN News account now.

ALL NEWS PUBLICATIONS

EIN News provides breaking news coverage on the following topics: